Nephros Inc (NEPH) support and resistance · P/E 48, rev $14.2M
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
This page maps Nephros Inc (NEPH) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
NEPH currently screens at market cap $40.9M and trailing P/E 48.3. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NEPH 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NEPH quote page for the session range and the stock page for the full model.
Not investment advice.